Covidh Technologies Ltd

📈 Covidh Technologies Acquires iSERA Biological in ₹78 Crore Share Swap Deal

- Acquisition of 100% equity of iSERA Biological Limited (1.62 crore shares) for ₹78 crore via share swap

- Authorized Share Capital increased from ₹11 crore to ₹25 crore, creating 1.4 crore additional equity shares of ₹10 each

- Swap ratio set at 1:1 for acquisition, with issue price fixed at ₹48.20 per share (premium ₹38.20)

- Valuation reports approved: iSERA Lifesciences fair value at ₹48.15 per share, iSERA Biological at ₹48.20 per share

- Preferential issue of up to 1.62 crore equity shares at ₹48.20 per share approved for iSERA Biological shareholders